Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 6
1985 1
1986 4
1987 8
1988 2
1989 2
1992 3
1993 5
1994 7
1995 6
1996 3
1997 6
1998 7
1999 7
2000 2
2001 2
2002 2
2003 3
2004 7
2005 10
2006 11
2007 13
2008 17
2009 16
2010 31
2011 21
2012 23
2013 27
2014 29
2015 22
2016 24
2017 31
2018 30
2019 15
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

390 results
Results by year
Filters applied: . Clear all
Page 1
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.
Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group. Smith CJ, et al. Among authors: el Sadr W. Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8. Lancet. 2014. PMID: 25042234
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group. Ryom L, et al. Among authors: El-Sadr W. Lancet HIV. 2018 Jun;5(6):e291-e300. doi: 10.1016/S2352-3018(18)30043-2. Epub 2018 May 3. Lancet HIV. 2018. PMID: 29731407 Clinical Trial.
Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team. Hayes RJ, et al. Among authors: El-Sadr W. N Engl J Med. 2019 Jul 18;381(3):207-218. doi: 10.1056/NEJMoa1814556. N Engl J Med. 2019. PMID: 31314965 Free PMC article. Clinical Trial.
Three months of rifapentine and isoniazid for latent tuberculosis infection.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. Sterling TR, et al. N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875. N Engl J Med. 2011. PMID: 22150035 Free article. Clinical Trial.
The Global HIV Epidemic: What Will It Take to Get to the Finish Line?
Katz IT, Ehrenkranz P, El-Sadr W. Katz IT, et al. Among authors: El-Sadr W. JAMA. 2018 Mar 20;319(11):1094-1095. doi: 10.1001/jama.2018.2093. JAMA. 2018. PMID: 29509836 No abstract available.
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.
Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Mave V, Rouzier V, Hesseling A, Shin K, Zimmer B, Costello D, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A; IMPAACT P1078 TB APPRISE Study Team. Gupta A, et al. N Engl J Med. 2019 Oct 3;381(14):1333-1346. doi: 10.1056/NEJMoa1813060. N Engl J Med. 2019. PMID: 31577875 Free PMC article. Clinical Trial.
Putting quality at the heart of HIV programs.
El-Sadr WM, Barker P, Rabkin M, Pillay Y, Birx D. El-Sadr WM, et al. AIDS. 2015 Jul;29 Suppl 2:S119-20. doi: 10.1097/QAD.0000000000000732. AIDS. 2015. PMID: 26102621 No abstract available.
The HIV response and global health.
Glass RI, El-Sadr W, Goosby E, Kupfer LE. Glass RI, et al. Among authors: El-Sadr W. Lancet. 2019 Apr 27;393(10182):1696. doi: 10.1016/S0140-6736(19)30353-8. Lancet. 2019. PMID: 31034374 No abstract available.
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.
Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group. Hatleberg CI, et al. Among authors: El-Sadr W. J Int AIDS Soc. 2018 Mar;21(3):e25083. doi: 10.1002/jia2.25083. J Int AIDS Soc. 2018. PMID: 29509305 Free PMC article.
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
Simonsen L, Higgs E, Taylor RJ, Wentworth D, Cozzi-Lepri A, Pett S, Dwyer DE, Davey R, Lynfield R, Losso M, Morales K, Glesby MJ, Weckx J, Carey D, Lane C, Lundgren J; INSIGHT FLU002 and FLU003 Study Groups. Simonsen L, et al. Clin Infect Dis. 2018 Jul 18;67(3):341-349. doi: 10.1093/cid/ciy088. Clin Infect Dis. 2018. PMID: 29746631 Free PMC article. Clinical Trial.
390 results
Jump to page
Feedback